ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Predictive value of prognostic nutritional and systemic immune-inflammation indices for patients with microsatellite instability-high metastatic colorectal cancer receiving immunotherapy

Yi, Jiahong; Xue, Ju; Yang, Lin; Xia, Liangping*; He, Wenzhuo*南方医科大学; 中山大学
Frontiers in Nutrition2023-5-18DOI: 10.3389/fnut.2023.1094189
3被引7阅读
引用收藏
分享

摘要

BackgroundThe prognostic nutritional index (PNI) and systemic immune-inflammation index (SII) are indicators of nutritional immune status. They have been reported associated with clinical outcomes of various solid tumors. However, it is unclear whether they can serve as predictors for patients with microsatellite instability-high (MSI-H) metastatic colorectal cancer (mCRC) receiving immunotherapy. Our objective was to study the prognostic value of PNI and SII in these patients. MethodsSeventy-five MSI-H mCRC patients were enrolled in our study. Logistic regression analysis was used to identify features that influenced immunotherapy response. Survival differences between groups of mCRC patients were compared using the Kaplan-Meier method and log-rank test. The independent risk parameters for progression-free survival (PFS) and overall survival (OS) of patients with MSI-H mCRC were established by Cox proportional risk regression analysis. ResultsThe optimal SII and PNI cutoff values were 409.6 and 51.35. Higher PNI (p = 0.012) and lower high-density lipoprotein cholesterol (HDLC, p = 0.012) were associated with a better immunotherapy response. SII (p = 0.031), cholesterol (CHO) (p = 0.007) and aspartate aminotransferase (AST) (p = 0.031) were independent prognostic factors correlated with OS. Higher PNI (p = 0.012) and lower AST (p = 0.049) were negative predictors of PFS. In addition, patients suffered from immune-related adverse events (irAEs) had a lower SII level (p = 0.04). ConclusionHigher AST and SII, and lower PNI predict worse outcomes in MSI-H mCRC patients undergoing immunotherapy. Moreover, patients with lower SII before immunotherapy suffered from irAEs more often.

学科与关键词

关键词
prognostic nutritional indeximmunotherapymCRCprognosissurvivalsystemic immune-inflammation index
相关
加载中…
  • Prognostic nutritional index for predicting the clinical outcomes of patients with gastric cancer who received immune checkpoint inhibitors
    Sun, Hao; Chen, Li; Huang, Rong; Pan, Hongming; Zuo, Yanjiao; Zhao, Ruihu; Xue, Yingwei; Song, Hongjiang*Frontiers in Nutrition, 2022, 9: 1038118.被引 9
  • Intrinsic resistance and efficacy of immunotherapy in microsatellite instability-high colorectal cancer: A systematic review and meta-analysis
    Wang, Ren; Lian, Jie; Wang, Xin; Pang, Xiangyi; Xu, Benjie; Tang, Shuli; Shao, Jiayue; Lu, Haibo*BIOMOLECULES AND BIOMEDICINE, 2023, 23(2): 198-208.被引 4
  • Prognostic value of nutritional and inflammatory markers in patients with hepatocellular carcinoma who receive immune checkpoint inhibitors
    Liu, Chunxun; Zhao, Haoran; Zhang, Rujia; Guo, Zuoming; Wang, Peng; Qu, Zhaowei*Oncology Letters, 2023, 26(4): 437.
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Nutrition
发表日期
2023-05-18
卷期
第 10 卷
页码
1094189
DOI
10.3389/fnut.2023.1094189
成果收录
SCIE
资助标注
National Science Fund for Distinguished Young Scholars of China [82002557]

作者

  • Y

    Yi, Jiahong (第一作者)

    sun yat sen univ

  • X

    Xue, Ju

    sun yat sen univ

查看全部 5 位作者收起作者
  • Y

    Yang, Lin

    southern med univ

  • X

    Xia, Liangping (通讯)

    sun yat sen univ

  • H

    He, Wenzhuo (通讯)

    sun yat sen univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417